**3.1 Methyl-ergometrine**

It is a vasoconstrictor and induces uterine contraction. It runs the risk of hypertension, coronary artery spasm and bronchospasm. Thus, it should not be used in concomitant cardiopulmonary diseases and pre-eclampsia. It may be used when the response to oxytocin is insufficient.
